透析液钾与镁及血液透析风险
本文综述影响血液透析患者钾平衡的因素及透析液钾浓度与心律失常、心血管事件和死亡的关系,并探讨血清与透析液镁的潜在交互作用,最后提出优化钾稳态的透析与非透析策略。
要点
- 血清和透析液钾浓度极端均可触发心脏骤停。
- 透析液钾选择需结合整体临床情境并加强血清钾监测。
- 血清与透析液镁水平可能影响透析液钾相关风险。
核心结论
- 观察性研究和间接证据提示血清与透析液钾浓度极端可触发心脏骤停,需优化透析钾管理以改善结局。
研究设计与样本
- 综述,总结影响钾平衡和透析钾通量的因素及钾浓度与心律失常、心血管事件和死亡的数据。
主要发现
- 观察性研究和间接证据提示血清和透析液钾浓度极端可触发心脏骤停。
- 综述探讨了血清与透析液镁水平的潜在交互作用及其与透析液钾相关风险的联系。
临床怎么用
- 选择透析液钾浓度时应考虑整体临床情境的变化。
- 有效改变实践需要更频繁的血清钾监测和响应迅速的透析护理团队。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
One of the fundamental goals of the hemodialysis prescription is to maintain serum potassium levels within a narrow normal range during both the intradialytic and interdialytic intervals. Considering the extraordinarily high rate of cardiovascular mortality in the hemodialysis population, clinicians are obligated to explore whether factors related to dialytic potassium removal can be modified to improve clinical outcomes. Observational studies and circumstantial evidence suggest that extreme concentrations of serum and dialysate potassium can trigger cardiac arrest. In this review, we provide an overview of factors affecting overall potassium balance and factors modulating potassium dialysate fluxes in dialysis, and we review data linking serum and dialysate potassium concentrations with arrhythmias, cardiovascular events, and mortality. We explore potential interactions between serum and dialysate magnesium levels and risks associated with dialysate potassium levels. Finally, we conclude with proposed dialytic and novel nondialytic approaches to optimize outcomes related to potassium homeostasis in patients on hemodialysis. Dialysis clinicians need to consider changes in the overall clinical scenario when choosing dialysate potassium concentrations, and an effective change in practice will require more frequent serum potassium monitoring and responsive dialysis care teams.
引用
- Pun PH, Middleton JP. Dialysate Potassium, Dialysate Magnesium, and Hemodialysis Risk. J Am Soc Nephrol. 2017. PMID: 28993507. doi:10.1681/ASN.2017060640
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。